1 Jun 2026
Population pharmacokinetics of lumefantrine in pregnant and non-pregnant Nigerian women receiving efavirenz-based antiretroviral therapyPublisher siteEuropean Journal of Clinical Pharmacology, HIV/AIDS drug development and treatment
UniversitiesOluseye O. Bolaji
Active, last published 2026
In malaria research and control
Oluseye O.
Bolaji
Scholar“Research focused on Malaria Research and Control and adjacent fields.”
Obafemi Awolowo University
Claim Your Profile19
H-index
983
Citations
Oluseye has not officially claimed their profile. If you are Oluseye, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
luseye O. Bolaji is a researcher working on Malaria Research and Control. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Oluseye's work has been cited 983 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Malaria Research and Control×20Pharmacogenetics and Drug Metabolism×18HIV/AIDS drug development and treatment×17HIV/AIDS Research and Interventions×13Drug Transport and Resistance Mechanisms×11
04 · Where I am
Affiliations
Affiliation on published researchObafemi Awolowo UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works26 Aug 2025Open access
A novel intron variant is associated with emerging pfdhps mutant haplotypes in West and Central African Plasmodium falciparumPublisher siteInternational Journal for Parasitology Drugs and Drug Resistance, Malaria Research and Control
15 Jul 2025Open access
Optimizing Amodiaquine Dosing in Nigeria: A Population Pharmacokinetic Study to Inform Seasonal Malaria ChemopreventionPublisher site24 Jun 2024Open access1cites
Prenatal efavirenz exposure is independently associated with maternal, but not fetal CYP2B6 genotypePublisher sitePharmacogenetics and Genomics, Pregnancy and Medication Impact
10 Jun 2024Open access2cites
Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and PostpartumPublisher siteClinical Pharmacology & Therapeutics, HIV/AIDS Research and Interventions
22 Feb 2024Open access1cites
Atazanavir/Ritonavir Increased Tizoxanide Exposure from Oral Nitazoxanide through Pharmacokinetic Interaction in Healthy VolunteersPublisher siteFuture Pharmacology, Cytomegalovirus and herpesvirus research
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Oluseye?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you